Showing 101 - 120 results of 1,405 for search '"immunotherapy"', query time: 0.11s Refine Results
  1. 101
  2. 102
  3. 103
  4. 104

    Ipilimumab, a Promising Immunotherapy with Increased Overall Survival in Metastatic Melanoma? by Gérald E. Piérard, François Aubin, Philippe Humbert

    Published 2012-01-01
    “…The therapeutic options remain limited for advanced MM, and those directed to the neoplastic cells have not brought major survival advantage so far. Immunotherapy is another targeted option. Ipilimumab, a monoclonal antibody directed to CTLA-4 present on cytotoxic T cells boosts immunity, particularly its anti-MM activity. …”
    Get full text
    Article
  5. 105

    Response of Immunotherapy to Tumour-TICLs Interactions: A Travelling Wave Analysis by Joseph Malinzi, Precious Sibanda, Hermane Mambili-Mamboundou

    Published 2014-01-01
    “…We present a travelling wave analysis of a tumour-immune interaction model with immunotherapy. We use the geometric treatment of an apt-phase space to establish the intersection between stable and unstable manifolds. …”
    Get full text
    Article
  6. 106
  7. 107

    Mutanome Engineered RNA Immunotherapy: Towards Patient-Centered Tumor Vaccination by Mathias Vormehr, Barbara Schrörs, Sebastian Boegel, Martin Löwer, Özlem Türeci, Ugur Sahin

    Published 2015-01-01
    “…In this review, we describe a process, which integrates next generation sequencing based cancer mutanome mapping, in silico target selection and prioritization approaches, and mRNA vaccine manufacturing and delivery into a process we refer to as MERIT (mutanome engineered RNA immunotherapy).…”
    Get full text
    Article
  8. 108
  9. 109
  10. 110
  11. 111
  12. 112

    Utilizing Cytokines to Function-Enable Human NK Cells for the Immunotherapy of Cancer by Rizwan Romee, Jeffrey W. Leong, Todd A. Fehniger

    Published 2014-01-01
    “…In the future, such strategies will be combined with negative regulatory signal blockade and enhanced recognition to comprehensively enhance NK cells for immunotherapy.…”
    Get full text
    Article
  13. 113
  14. 114
  15. 115

    Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer Immunotherapy by Rangarirai Makuku, Neda Khalili, Sepideh Razi, Mahsa Keshavarz-Fathi, Nima Rezaei

    Published 2021-01-01
    “…Cancer immunotherapy, which reactivates weakened immune cells of cancer patients, has yielded great success in recent years. …”
    Get full text
    Article
  16. 116

    Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer by Carmine Carbone, Geny Piro, Vincenzo Di Noia, Ettore D’Argento, Emanuele Vita, Miriam Grazia Ferrara, Sara Pilotto, Michele Milella, Giovanni Cammarota, Antonio Gasbarrini, Giampaolo Tortora, Emilio Bria

    Published 2019-01-01
    “…Lung cancer is one of the deadliest and most common malignancies in the world, representing one of the greatest challenges in cancer treatment. Immunotherapy is rapidly changing standard treatment schedule and outcomes for patients with advanced malignancies. …”
    Get full text
    Article
  17. 117
  18. 118
  19. 119
  20. 120

    A New Hope in Immunotherapy for Malignant Gliomas: Adoptive T Cell Transfer Therapy by Dong-Sup Chung, Hye-Jin Shin, Yong-Kil Hong

    Published 2014-01-01
    “…Immunotherapy emerged as a promising therapeutic approach to highly incurable malignant gliomas due to tumor-specific cytotoxicity, minimal side effect, and a durable antitumor effect by memory T cells. …”
    Get full text
    Article